title: Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.
authors.affiliation: Department of Medicine, Hurley Medical Center, Flint, MI, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kaatz
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Michigan State University, East Lansing, MI, USA.
authors.forename: D
authors.initials: D
authors.lastname: Ahmad
authors.affiliation: Anticoagulation and Clinical Thrombosis Services, North Shore-LIJ Health System; Department ;of Medicine, Hofstra North Shore-LIJ School of Medicine, Manhasset, NY, USA.
authors.forename: A C
authors.initials: AC
authors.lastname: Spyropoulos
authors.affiliation: Department of Medicine, Thrombosis Service, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Schulman
mesh_terms: D000991:Antithrombins / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications*; D017326:Clinical Trials, Phase III as Topic; D065427:Factor Xa Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced* / Q000175:diagnosis; D006760:Hospitalization; D006801:Humans; D010342:Patient Acceptance of Health Care; D011788:Quality of Life; D012720:Severity of Illness Index; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D000991:Antithrombins; D065427:Factor Xa Inhibitors